These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18661143)

  • 21. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1991 May; 98(5 Suppl):766-85. PubMed ID: 2062512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic macular oedema: pilot randomised trial of pars plana vitrectomy vs macular argon photocoagulation.
    Patel JI; Hykin PG; Schadt M; Luong V; Bunce C; Fitzke F; Gregor ZJ
    Eye (Lond); 2006 Aug; 20(8):873-81. PubMed ID: 16052254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow up.
    Sivaprasad S; Sandhu R; Tandon A; Sayed-Ahmed K; McHugh DA
    Clin Exp Ophthalmol; 2007; 35(7):640-4. PubMed ID: 17894684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
    Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
    Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Visual prognosis and prognostic risk factors after photocoagulation for diffuse diabetic macular edema].
    Ohkoshi K
    Nippon Ganka Gakkai Zasshi; 2005 Apr; 109(4):210-7. PubMed ID: 15859151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.
    Chew EY; Benson WE; Remaley NA; Lindley AA; Burton TC; Csaky K; Williams GA; Ferris FL
    Arch Ophthalmol; 1999 Dec; 117(12):1600-6. PubMed ID: 10604663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
    Sander B; Larsen M; Moldow B; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binocular fixation topography in patients with diabetic macular oedema: possible implications for photocoagulation therapy (3rd revision).
    Møller F; Laursen ML; Sjølie AK
    Graefes Arch Clin Exp Ophthalmol; 2005 Sep; 243(9):903-10. PubMed ID: 15834607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.
    Chew EY; Ferris FL; Csaky KG; Murphy RP; Agrón E; Thompson DJ; Reed GF; Schachat AP
    Ophthalmology; 2003 Sep; 110(9):1683-9. PubMed ID: 13129862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
    Ebneter A; Wolf S; Zinkernagel MS
    Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
    Michaelides M; Kaines A; Hamilton RD; Fraser-Bell S; Rajendram R; Quhill F; Boos CJ; Xing W; Egan C; Peto T; Bunce C; Leslie RD; Hykin PG
    Ophthalmology; 2010 Jun; 117(6):1078-1086.e2. PubMed ID: 20416952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion.
    Astam N; Batioğlu F; Ozmert E
    Int Ophthalmol; 2009 Oct; 29(5):343-8. PubMed ID: 18553061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aqueous flare and macular edema in eyes with diabetic retinopathy.
    Jandrasits K; Krepler K; Wedrich A
    Ophthalmologica; 2003; 217(1):49-52. PubMed ID: 12566873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of macular laser photocoagulation on contrast sensitivity function in patients with clinically significant macular edema.
    Farahvash MS; Mahmoudi AH; Farahvash MM; Tabatabaee A; Riazi M; Mohammadzadeh S; Faghihi H; Nilli-Ahmadabadi M; Mirshahi A; Karkhaneh R; Aalami-Harandi Z; Javadian A; Abdolahi A; Lashey A
    Arch Iran Med; 2008 Mar; 11(2):143-7. PubMed ID: 18298289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series.
    Javadzadeh A
    BMC Ophthalmol; 2006 Apr; 6():15. PubMed ID: 16595011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.
    Aiello LP; Vignati L; Sheetz MJ; Zhi X; Girach A; Davis MD; Wolka AM; Shahri N; Milton RC;
    Retina; 2011 Nov; 31(10):2084-94. PubMed ID: 21862954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.